CashCropToday | 411/420 | Cannapreneur & Social Equity Advocate Bo Money | Part 2 | CashCropToday
0 Shares 709 Views

CashCropToday | 411/420 | Cannapreneur & Social Equity Advocate Bo Money | Part 2

October 4, 2018
709 Views

In this episode of 411/420, Host Joya Italiano talks with Bonita “Bo” Money, Founder of Women Abuv Ground and NDICA, about the impact the war on drugs has had on low-income communities and how she aims to reverse the effects. Before the legalization of cannabis in some states, many people, especially men of color, have been incarcerated because of marijuana possession. Now, as more states begin to legalize recreational use, those very people are being pushed out of the industry due to the many barriers set up.

Watch 411/420’s episode featuring guest star Bo Money (Part 2) to discover how her Social Equity Plan will remove the imposed barriers and provide benefits to low-income communities.

Be sure to check out Part 1 of this episode to learn about the Women Abuv Ground movement and the Social Equity Program’s goal to assist minorities in owning a cannabis business after a previous cannabis conviction.

 

 

411/420 PRODUCTION CREW
Executive Producer – Dave Hill, Lamar Seay
Producer – Alex Fraser
Associate Producer – Sam Rosenberg
Director – Naim Reece
Camera 1 – Ernie Chavarria
Camera 2 – Christiaan Adams
Editor – Filmed By Erika

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
251 views
Market Watch
251 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
180 views
Global
180 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
177 views
Manufacturing
177 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: